Polymerase Chain Reaction (PCR) Technologies and Global Markets

Sep 26, 2011, 03:58 ET from Reportlinker

NEW YORK, Sept. 26, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Polymerase Chain Reaction (PCR) Technologies and Global Markets

http://www.reportlinker.com/p0619271/Polymerase-Chain-Reaction-PCR-Technologies-and-Global-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

REPORT HIGHLIGHTS

* The global PCR products market is expected to grow from nearly $5 billion in 2010 to nearly $8 billion by 2015, at an estimated compound annual growth rate (CAGR) of 9.9% from 2010 to 2015.

* The reagents and consumables segment accounted for the largest share at nearly $2.7 billion in 2010 and is expected to grow to nearly $4.4 billion at a compound annual growth rate (CAGR) of 10.5% from 2010 to 2015.

* The Instruments segment reached at $1.7 billion in 2010 and is expected to grow to nearly $2.7 billion at a compound annual growth rate (CAGR) of 9.6% from 2010 to 2015.

REPORT SCOPE

INTRODUCTION

STUDY GOALS AND OBJECTIVES

The core objective of the report is to provide an in-depth analysis of the polymerase chain reaction (PCR) market with respect to key market trends, competitive intelligence, and market forecasts. The report also aims at providing key decision-making parameters such as new product launches, market strategies, key application areas to support the market estimates, and forecast data. The report also aims at providing key analysis and strategic recommendations derived from intensive primary and secondary research.

REASONS FOR DOING THIS STUDY

Increasing demand for technologies supporting early and accurate diagnosis of life-threatening diseases, such as cancer, is driving the market for PCR. Additionally, investment in research is increasing with respect to gene therapy, the Human Genome Project (HGP), etc. Despite the economic recession, these investments are further driving the growth of the PCR market. PCR is increasingly being applied in key research that is expected to solve numerous medical mysteries and breakthrough technologies supporting drug discovery. Hence, it is crucial for market participants to understand the growing opportunities and changing market scenarios across the globe. This report therefore aims at providing such crucial information, which will enable companies in this market to make informed decisions.

INTENDED AUDIENCE

Key stakeholders of the report include key decision makers such as CEOs, VPs, AVPs, marketing heads, research heads of the PCR manufacturers, technology providers, software providers, and service providers. The report would also be useful to existing biotech instrumentation players looking to enter high-growth markets. End users, such as healthcare, pharmaceutical companies and drug discovery companies, may also use this report to understand the level of adoption and technology types used in this environment. Universities and consulting firms may derive in-depth market intelligence with respect to the PCR market holistically.

SCOPE AND FORMAT

The key PCR markets covered in the report are the markets for instruments, reagents, consumables and accessories, software, and services, as well as PCR applications and technologies.

The PCR instruments market includes buffers and deoxynucleotide triphosphates [dNTPs] (buffers, contamination control kits, dNTP mixes), controls and cDNAs, primers (real-time PCR primers, human linkage mapping sets, mouse mapping primers), PCR enzymes and kits (contamination control kits, general PCR, fast PCR, multiplex PCR, wax beads for hot start PCR, high-fidelity PCR kits, and other kits), accessories, reaction plates, adhesive films, and thermal cyclers.

The other markets include reagents and consumables, and other accessories (PCR plates and frames, PCR tubes, PCR sealers, PCR plastics). The PCR software market includes primer design and sequencing software, PCR analyzer software, integrated software, and others.

The PCR application market includes research (e.g., genetic testing, gene expression, genetic mapping, tissue typing, hybridization probes, DNA sequencing, the Human Genome Project, forensic science, DNA cloning, bioinformatics, and others), diagnosis (a) infectious disease, for example, HIV, tuberculosis, spread of disease organisms, others, (b) cancer, and (c) prenatal diagnosis and genetic abnormalities, and drug discovery.

The PCR technology market includes inverse PCR, in situ PCR, real-time PCR, reverse transcriptase PCR, nested PCR, long PCR, single cell PCR, and others.

METHODOLOGY AND INFORMATION SOURCES

The market estimates in the report are based on both primary and secondary research. Intensive questionnaire and discussion guides were used to gather data from industry participants, key opinion leaders, and other market specialists across the targeted geographic segments. The market data are further validated through decision support databases and top down market analysis. The secondary research was performed through both paid sources and other domain-based subscription sites and other sources such as company websites, Google searches, freepatentsonline.com, etc.

CHAPTER ONE: INTRODUCTION 1

STUDY GOALS AND OBJECTIVES 1

REASONS FOR DOING THIS STUDY 1

INTENDED AUDIENCE 1

SCOPE AND FORMAT 2

METHODOLOGY AND INFORMATION SOURCES 2

ANALYST CREDENTIALS 3

RELATED BCC RESEARCH REPORTS 3

BCC RESEARCH ONLINE SERVICES 3

DISCLAIMER 4

CHAPTER TWO: SUMMARY 5

SUMMARY 5

SUMMARY TABLE A GLOBAL PCR TECHNOLOGIES MARKET BY

SEGMENT, THROUGH 2015 ($ MILLIONS) 6

SUMMARY FIGURE GLOBAL PCR TECHNOLOGIES MARKET BY

SEGMENT, 2008-2015 ($ MILLIONS) 7

DRIVERS 7

RAPID PROGRESS IN PROTEOMICS AND GENOMICS 7

AVAILABILITY OF FUNDING INCREASES TECHNOLOGY

DEVELOPMENT AND ADOPTION 8

RAPID GROWTH IN MOLECULAR DIAGNOSTIC INDUSTRY 9

PRODUCT INNOVATIONS INCREASE TECHNOLOGY

ADOPTION AND APPLICATION AREAS 10

WIDE RANGE OF APPLICATIONS 11

RESTRAINTS 11

LACK OF AWARENESS 11

REQUIREMENT OF SKILLED LABOR 11

HIGH COST OF REAL-TIME PCR INSTRUMENTS 12

DEVELOPMENT OF ALTERNATIVE TECHNOLOGIES 12

OPPORTUNITIES AND CHALLENGES 12

SUMMARY TABLE B GLOBAL PCR TECHNOLOGIES MARKET BY

GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 13

CHAPTER THREE: MARKET OVERVIEW 14

EVOLUTION OF PCR TECHNOLOGY AND ITS IMPACT ON THE

HEALTHCARE INDUSTRY 14

FIGURE 1 IMPACT OF PCR TECHNOLOGY ON THE HEALTHCARE

ENVIRONMENT 15

TRADITIONAL PCR VERSUS REAL-TIME PCR 16

TABLE 1 TRADITIONAL PCR VERSUS REAL-TIME PCR 16

KEY APPLICATION AREAS 17

FIGURE 2 KEY APPLICATIONS OF PCR TECHNOLOGY 17

PCR QUANTITATION METHODS 18

THE HUMAN GENOME PROJECT AND PCR 19

HUMAN MICROBIOME PROJECT AND PCR 20

TAQMAN PROBES AND MOLECULAR BEACONS: POTENTIAL

ALTERNATIVES TO DYES USED IN REAL-TIME PCR 21

ALTERNATIVES TO PCR-BASED ANALYTICAL METHODS 22

FIGURE 3 DISADVANTAGES OF PCR VS THE ADVANTAGES OF

ALTERNATIVES 22

LOOP MEDIATED ISOTHERMAL AMPLIFICATION 23

REACTION DISPLACEMENT CHIMERIC 24

NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION 24

TRANSCRIPTION-MEDIATED AMPLIFICATION 24

KEY APPLICATION AREAS 25

FIGURE 4 KEY APPLICATIONS OF PCR 25

PCR AND PUBLIC HEALTH SURVEILLANCE 26

PCR AND PUBLIC HEALTH SURVEILLANCE (CONTINUED) 27

EMERGING ECONOMIES AND TECHNOLOGY ADOPTION 28

FUTURE OF PCR 28

MARKET TRENDS/KEY INSIGHTS 29

KEY RECOMMENDATIONS/MARKET STRATEGIES 29

PATENT ANALYSIS 30

FIGURE 5 PATENT ANALYSIS BY GEOGRAPHIC REGION, 2008–2010

(%) 31

FIGURE 6 PATENT ANALYSIS BY TYPE OF PRODUCT, 2008–2010 (%) 32

CHAPTER FOUR: PCR MARKET SEGMENTS 33

INSTRUMENTS MARKET 33

TABLE 2 GLOBAL PCR INSTRUMENTS MARKET BY PRODUCT

TYPE, THROUGH 2015 ($ MILLIONS) 33

TABLE 3 GLOBAL PCR INSTRUMENTS MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 34

DRIVERS AND RESTRAINTS 34

MARKET FLOODED WITH CHOICE OF INSTRUMENTS

WITH A WIDE RANGE OF PRICES 34

GROWING POPULARITY OF REAL-TIME PCR

INSTRUMENTS 35

RAPIDLY CHANGING MARKET DEMAND 36

TRADITIONAL THERMAL CYCLERS/THERMAL CYCLERS 36

TABLE 4 GLOBAL THERMAL CYCLERS MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 37

REAL-TIME PCR INSTRUMENTS/REAL-TIME THERMAL

CYCLERS 37

TABLE 5 GLOBAL REAL-TIME PCR INSTRUMENTS MARKET BY

GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 38

OTHERS 38

TABLE 6 GLOBAL OTHER INSTRUMENTS MARKET BY

GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 38

REAGENTS AND CONSUMABLES MARKET 39

TABLE 7 GLOBAL REAGENTS AND CONSUMABLES MARKET BY

PRODUCT TYPE, THROUGH 2015 ($ MILLIONS) 39

TABLE 8 GLOBAL REAGENTS AND CONSUMABLES MARKET BY

GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 40

DRIVERS 40

Increased Use of PCR Technology 40

Master Mixes and Ready-to-Use Kits Boost the Market 41

RESTRAINTS 41

REAGENTS 42

TABLE 9 GLOBAL REAGENTS MARKET BY PRODUCT TYPE,

THROUGH 2015 ($ MILLIONS) 42

TABLE 10 GLOBAL REAGENTS MARKET BY GEOGRAPHIC REGION,

THROUGH 2015 ($ MILLIONS) 43

Individual Reagents 43

TABLE 11 GLOBAL INDIVIDUAL REAGENTS BY PRODUCT TYPE,

THROUGH 2015 ($ MILLIONS) 43

TABLE 12 GLOBAL INDIVIDUAL REAGENTS BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 44

Enzymes 44

TABLE 13 GLOBAL ENZYMES MARKET BY GEOGRAPHIC REGION,

THROUGH 2015 ($ MILLIONS) 45

Deoxynucleotide Triphosphates 45

TABLE 14 GLOBAL DNTP MARKET BY GEOGRAPHIC REGION,

THROUGH 2015 ($ MILLIONS) 46

Buffers/Reaction Buffers and Additives 46

TABLE 15 GLOBAL BUFFERS AND ADDITIVES MARKET BY

GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 47

Primers and Probes 47

TABLE 16 GLOBAL PRIMERS AND PROBES MARKET BY

GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 48

Controls/Templates 48

TABLE 17 GLOBAL TEMPLATES MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 49

Master Mixes/Reagents Kits 49

TABLE 18 GLOBAL MASTER MIXES MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 50

Other Reagents 50

TABLE 19 GLOBAL OTHER REAGENTS MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 50

CONSUMABLES 51

TABLE 20 GLOBAL CONSUMABLES MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 51

PCR SOFTWARE 51

TABLE 21 GLOBAL PCR SOFTWARE MARKET BY PRODUCT TYPE,

THROUGH 2015 ($ MILLIONS) 52

TABLE 22 GLOBAL PCR SOFTWARE MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 52

PRIMER DESIGN AND SEQUENCING SOFTWARE 53

TABLE 23 GLOBAL PRIMER DESIGN AND SEQUENCING

SOFTWARE MARKET BY GEOGRAPHIC REGION, THROUGH 2015

($ MILLIONS) 53

PCR ANALYZER SOFTWARE 53

TABLE 24 GLOBAL PCR ANALYZER SOFTWARE MARKET BY

GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 54

OTHER SOFTWARE MARKET 54

TABLE 25 GLOBAL OTHER SOFTWARE MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 54

SERVICES 55

TABLE 26 GLOBAL PCR SERVICE MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 55

CHAPTER FIVE: PCR APPLICATION MARKET 56

TABLE 27 GLOBAL APPLICATION MARKET BY SEGMENT,

THROUGH 2015 ($ MILLIONS) 56

TABLE 28 GLOBAL APPLICATION MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 57

DRIVERS 57

PRESSING NEED FOR MANAGEMENT OF INFECTIOUS

AND FATAL DISEASES 57

IMPROVEMENTS IN PCR PRODUCTS AND AVAILABILITY

HAVE FACILITATED USE 57

CAPABILITY TO ANALYZE OLD/ANCIENT SAMPLES 58

FOCUS ON PREVENTIVE HEALTHCARE 58

DEMAND FOR GENETIC, MOLECULAR DIAGNOSTIC

TESTING 59

NEWER TECHNOLOGIES AND AN INCREASE IN END

USERS 59

RESTRAINTS AND CHALLENGES 59

RESEARCH APPLICATIONS 60

TABLE 29 GLOBAL RESEARCH MARKET BY APPLICATION TYPE,

THROUGH 2015 ($ MILLIONS) 60

TABLE 30 GLOBAL RESEARCH APPLICATION MARKET BY

GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 61

DNA SEQUENCING 61

TABLE 31 GLOBAL DNA SEQUENCING MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 62

FORENSIC SCIENCE 62

Forensic Science (Continued) 63

TABLE 32 GLOBAL FORENSIC SCIENCE MARKET BY GEOGRAPHIC

REGION, 2008–2015 ($ MILLIONS) 64

GENOTYPING 64

TABLE 33 GLOBAL GENOTYPING MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 65

BIOINFORMATICS 65

TABLE 34 GLOBAL BIOINFORMATICS MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 66

GENE EXPRESSION AND GENETIC MAPPING 66

TABLE 35 GLOBAL GENE EXPRESSION AND GENETIC MAPPING

MARKET BY GEOGRAPHIC REGION, THROUGH 2015 ($

MILLIONS) 67

DNA CLONING 67

TABLE 36 GLOBAL DNA CLONING MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 68

OTHERS 68

TABLE 37 GLOBAL OTHER RESEARCH APPLICATIONS MARKET BY

GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 68

CLINICAL APPLICATIONS 69

TABLE 38 GLOBAL PCR MARKET BY TYPE OF CLINICAL

APPLICATION, THROUGH 2015 ($ MILLIONS) 69

TABLE 39 GLOBAL CLINICAL APPLICATIONS MARKET BY

GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 70

PRENATAL DIAGNOSIS 70

TABLE 40 GLOBAL MARKET FOR PCR IN PRENATAL DIAGNOSTICS

BY GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 70

TISSUE TYPING/TRANSPLANT 71

TABLE 41 GLOBAL PCR TISSUE TYPING/TRANSPLANT

INSTRUMENTS MARKET BY GEOGRAPHIC REGION, THROUGH

2015 ($ MILLIONS) 71

CANCER THERAPY AND DETERMINATION 71

TABLE 42 GLOBAL MARKET FOR PCR TESTING IN CANCER

THERAPY BY GEOGRAPHIC REGION, THROUGH 2015 ($

MILLIONS) 72

INFECTIOUS DISEASE DIAGNOSIS 72

TABLE 43 GLOBAL MARKET FOR PCR IN THE TESTING OF

INFECTIOUS DISEASES BY APPLICATION TYPE, THROUGH

2015 ($ MILLIONS) 73

TABLE 44 GLOBAL MARKET FOR PCR IN THE TESTING OF

INFECTIOUS DISEASES BY GEOGRAPHIC REGION, THROUGH

2015 ($ MILLIONS) 73

Hepatitis B and Hepatitis C Testing 74

TABLE 45 GLOBAL MARKET FOR PCR IN HEPATITIS B AND C

TESTING BY GEOGRAPHIC REGION, THROUGH 2015 ($

MILLIONS) 75

Tuberculosis Diagnosis 75

TABLE 46 GLOBAL MARKET FOR PCR IN TUBERCULOSIS TESTING

BY GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 76

HIV/AIDS Diagnosis 76

TABLE 47 GLOBAL HIV TESTING MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 77

Other Infectious Diseases 77

TABLE 48 GLOBAL MARKET FOR PCR TESTING OF OTHER

INFECTIOUS DISEASES BY GEOGRAPHIC REGION, THROUGH

2015 ($ MILLIONS) 77

GENETIC TESTING 78

TABLE 49 GLOBAL GENETIC TESTING MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 78

BLOOD SCREENING 79

TABLE 50 GLOBAL MARKET FOR PCR BLOOD SCREENING TESTS

BY GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 79

OTHER PCR APPLICATIONS 79

TABLE 51 GLOBAL "OTHER" PCR APPLICATIONS MARKET BY

GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 80

CHAPTER SIX: PCR TECHNOLOGY MARKET 81

TECHNOLOGY TYPES 81

TABLE 52 GLOBAL PCR TECHNOLOGY MARKET BY TYPE,

THROUGH 2015 ($ MILLIONS) 81

TABLE 53 GLOBAL PCR TECHNOLOGY MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 82

MARKET DRIVERS 82

WIDE RANGE OF APPLICATIONS DRIVING TECHNOLOGY

ACCEPTANCE 82

TECHNOLOGICAL VARIANTS OPEN NEW AVENUES FOR

PCR TECHNOLOGY 83

PCR TECHNOLOGY PATENT EXPIRY HAS BOOSTED

MARKET GROWTH 83

CHALLENGES 84

STANDARD/BASIC PCR 84

TABLE 54 GLOBAL STANDARD PCR MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 84

REAL-TIME PCR/QPCR 85

TABLE 55 GLOBAL REAL-TIME PCR/QPCR MARKET BY

GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 86

REVERSE TRANSCRIPTASE PCR 86

TABLE 56 GLOBAL REVERSE TRANSCRIPTION PCR MARKET BY

GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 87

ASSEMBLY PCR 87

TABLE 57 GLOBAL ASSEMBLY PCR MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 88

INVERSE PCR 88

TABLE 58 GLOBAL INVERSE MARKET BY GEOGRAPHIC REGION,

THROUGH 2015 ($ MILLIONS) 89

NESTED PCR 89

TABLE 59 GLOBAL NESTED PCR MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 90

MULTIPLEX PCR 90

TABLE 60 GLOBAL MULTIPLEX PCR MARKET BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 90

HOT START AND TOUCHDOWN PCR 91

TABLE 61 GLOBAL HOT START AND TOUCHDOWN PCR MARKET

BY GEOGRAPHIC REGION, THROUGH 2015 ($ MILLIONS) 91

OTHERS 92

TABLE 62 GLOBAL OTHER TECHNOLOGY TYPES BY GEOGRAPHIC

REGION, THROUGH 2015 ($ MILLIONS) 92

CHAPTER SEVEN: COMPETITIVE LANDSCAPE 93

FIGURE 7 PCR MARKET STRATEGIES BY TYPE, MARCH 2008-2010

(%) 93

COMPETITIVE LANDSCAPE (CONTINUED) 94

FIGURE 8 KEY PLAYERS IN STRATEGIC DEVELOPMENT (%) 95

TABLE 63 MERGERS AND ACQUISITIONS 96

TABLE 64 NEW PRODUCT LAUNCHES, JUNE 2008-MAY 2011 96

TABLE 64 (CONTINUED) 97

TABLE 65 AGREEMENTS AND COLLABORATIONS, JUNE 2008 TO

JUNE 2011 97

TABLE 65 (CONTINUED) 98

CHAPTER EIGHT: GEOGRAPHIC ANALYSIS OF THE PCR

APPLICATIONS MARKET 99

FIGURE 9 TOTAL PCR MARKET BY GEOGRAPHIC REGION, 2010 VS

2015 (%) 99

FIGURE 9 (CONTINUED) 100

NORTH AMERICA 101

TABLE 66 NORTH AMERICAN PCR MARKET BY SEGMENT, 2008–

2015 ($ MILLIONS) 101

EUROPE 101

TABLE 67 EUROPEAN PCR MARKET BY SEGMENT, 2008–2015 ($

MILLIONS) 102

ASIA 102

TABLE 68 ASIAN PCR MARKET BY SEGMENT, THROUGH 2015 ($

MILLIONS) 103

ROW 103

TABLE 69 ROW PCR MARKET BY SEGMENT, THROUGH 2015 ($

MILLIONS) 104

CHAPTER NINE: COMPANY PROFILES 105

ABBOTT LABORATORIES 105

TABLE 70 RECENT DEVELOPMENTS 105

TABLE 70 (CONTINUED) 106

AFFYMETRIX, INC 106

TABLE 71 RECENT DEVELOPMENTS 107

AGILENT TECHNOLOGIES 107

TABLE 72 RECENT DEVELOPMENTS 108

BECKMAN COULTER, INC 109

TABLE 73 RECENT DEVELOPMENTS 110

BECTON, DICKINSON AND CO 110

TABLE 74 RECENT DEVELOPMENTS 111

BIOLINE 112

BIONEER, INC 112

TABLE 75 RECENT DEVELOPMENTS 113

BIO-RAD 114

TABLE 76 RECENT DEVELOPMENTS 114

COMPLETE GENOMICS 115

TABLE 77 RECENT DEVELOPMENTS 115

TABLE 77 (CONTINUED) 116

THE ELITECH GROUP (NANOGEN/EPOCH BIOSCIENCES) 116

ENZO LIFE SCIENCES (ENZO BIOCHEM SUBSIDIARY) 117

EXIQON 117

TABLE 78 RECENT DEVELOPMENTS 118

GE HEALTHCARE 119

TABLE 79 RECENT DEVELOPMENTS 119

GEN-PROBE, INC 120

TABLE 80 RECENT DEVELOPMENTS 120

HY LABORATORIES (HY LABS) 121

IDAHO TECHNOLOGY, INC 121

TABLE 81 RECENT DEVELOPMENTS 122

ILLUMINA 123

TABLE 82 RECENT DEVELOPMENTS 124

KAPA BIOSYSTEMS 124

LIFE TECHNOLOGIES CORP/APPLIED BIOSYSTEMS AND

INVITROGEN 125

TABLE 83 RECENT DEVELOPMENTS 126

TABLE 83 (CONTINUED) 127

LUCIGEN 128

MAXIM BIOTECH 128

NEW ENGLAND BIOLABS (NEB) 129

TABLE 84 RECENT DEVELOPMENTS 130

OCIMUM BIOSOLUTIONS, LTD 130

PROMEGA CORP 131

TABLE 85 RECENT DEVELOPMENTS 132

QIAGEN NV 133

TABLE 86 RECENT DEVELOPMENTS 133

TABLE 86 (CONTINUED) 134

TABLE 86 (CONTINUED) 135

ROCHE 136

TABLE 87 RECENT DEVELOPMENTS 137

TABLE 87 (CONTINUED) 138

TABLE 87 (CONTINUED) 139

SIGMA-ALDRICH CORP 139

TABLE 88 RECENT DEVELOPMENTS 140

TABLE 88 (CONTINUED) 141

TAKARA BIO 142

TABLE 89 RECENT DEVELOPMENTS 143

THERMO FISHER SCIENTIFIC 143

TABLE 90 RECENT DEVELOPMENTS 144

QUANTA BIOSCIENCES 145

APPENDIX: LIST OF PATENTS 146

TABLE 91 US PATENTS AND PATENT APPLICATIONS (2008 TO

2011) 146

TABLE 93 JAPANESE PATENTS (2008 TO 2011) 155

To order this report:

Genomics Industry: Polymerase Chain Reaction (PCR) Technologies and Global Markets

Genomics Business News

More  Market Research Report

Check our  Industry Analysis and Insights

__________________________

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com